Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

43.90
Delayed Data
As of Oct 23
 +0.18 / +0.41%
Today’s Change
38.40
Today|||52-Week Range
67.88
-28.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues160.9M88.3M102.8M206.6M
 
 
 
 
 
Depreciation And Amortization639.0K1.7M2.1M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses36.1M55.8M76.1M115.8M
 
 
 
 
 
Research And Development23.2M40.5M57.5M94.9M
 
 
 
 
 
Total Operating Expenses36.7M57.4M78.2M118.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income124.1M30.8M24.6M88.3M
 
 
 
 
 
Extraordinary Credit347.0K29.0K0.000.00
 
 
 
Extraordinary Charge0.000.00-159.0K-59.0K
 
 
 
Interest Expense On Debt8.0K45.0K40.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income125.5M32.6M26.9M93.1M
 
 
 
 
 
Income Taxes-46.5M-10.9M-9.2M-21.2M
 
 
 
 
 
Net Income79.0M21.7M17.7M72.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M18.9M19.1M19.3M
 
 
 
 
 
Shares To Calculate EPS Diluted19.3M19.2M19.4M20.7M
 
 
 
 
 
 
Earnings Per ShareEPS$4.09$1.13$0.91$3.48
 
 
 
 
 
EPS Diluted$4.09$1.13$0.91$3.48